PARP1 and ulcerative colitis: Similar to the LPS-mediated sepsis model, PARP1−/− mice were protected from ulcerative colitis induced by trinitrobenzene sulfonic acid (TNBS) treatment, because PARP1 can activate c-Jun of the AP-1 transcription factor [123].